Studies Describe Stromal Cell Role in Aggressive Colorectal Cancer Signature | GenomeWeb

NEW YORK (GenomeWeb) – The gene expression patterns in tumor-adjacent stromal cells appear to be particularly telling when trying to predict outcomes for patients with some colorectal cancer subtypes, new research suggests.

Studies by independent research teams reporting in Nature Genetics today delved into the stromal-like expression signatures detected in a subset of CRC tumors known for enhanced treatment resistance and diminished disease-free survival times.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.